NICE Ltd. (NASDAQ:NICE - Free Report) - Cantor Fitzgerald boosted their FY2025 earnings per share estimates for NICE in a research note issued on Monday, May 19th. Cantor Fitzgerald analyst T. Blakey now expects that the technology company will post earnings of $10.03 per share for the year, up from their prior forecast of $9.92. Cantor Fitzgerald currently has a "Neutral" rating and a $161.00 price target on the stock. The consensus estimate for NICE's current full-year earnings is $9.85 per share.
NICE (NASDAQ:NICE - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The technology company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.84 by $0.03. NICE had a return on equity of 16.17% and a net margin of 16.18%. The company had revenue of $700.19 million during the quarter, compared to analysts' expectations of $699.46 million. During the same period last year, the business earned $2.58 earnings per share. NICE's quarterly revenue was up 6.2% on a year-over-year basis.
NICE has been the subject of a number of other research reports. DA Davidson lifted their price objective on shares of NICE from $180.00 to $185.00 and gave the company a "buy" rating in a report on Friday, May 16th. Barclays reduced their price target on NICE from $286.00 to $226.00 and set an "overweight" rating for the company in a report on Friday, February 21st. Wedbush reaffirmed an "outperform" rating and issued a $200.00 price target on shares of NICE in a research note on Friday, May 16th. Citigroup reduced their price objective on NICE from $214.00 to $211.00 and set a "buy" rating for the company in a research note on Monday. Finally, JMP Securities reiterated a "market outperform" rating and issued a $300.00 target price on shares of NICE in a research report on Friday, May 16th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $211.50.
Check Out Our Latest Analysis on NICE
NICE Price Performance
NICE opened at $166.48 on Wednesday. The firm has a fifty day moving average price of $155.02 and a 200 day moving average price of $165.08. NICE has a 1 year low of $137.19 and a 1 year high of $202.33. The stock has a market cap of $10.53 billion, a P/E ratio of 24.63, a P/E/G ratio of 1.07 and a beta of 1.03.
Hedge Funds Weigh In On NICE
A number of hedge funds have recently modified their holdings of the business. Avion Wealth purchased a new stake in NICE in the 4th quarter valued at about $25,000. Tradewinds Capital Management LLC acquired a new stake in shares of NICE during the fourth quarter valued at about $25,000. Anchor Investment Management LLC raised its stake in shares of NICE by 200.0% in the 4th quarter. Anchor Investment Management LLC now owns 150 shares of the technology company's stock valued at $25,000 after acquiring an additional 100 shares during the period. Park Square Financial Group LLC acquired a new position in shares of NICE in the 4th quarter worth approximately $25,000. Finally, McIlrath & Eck LLC boosted its position in shares of NICE by 56.9% during the 4th quarter. McIlrath & Eck LLC now owns 160 shares of the technology company's stock worth $27,000 after purchasing an additional 58 shares during the period. 63.34% of the stock is currently owned by hedge funds and other institutional investors.
NICE Company Profile
(
Get Free Report)
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NICE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.
While NICE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.